The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Intervention ¹

Added text ² to state that the U.S. Food and Drug Administration has reviewed information on the use of erythropoiesis-stimulating agents (ESAs) for chemotherapy-induced anemia in cancer patients and has revised the safety data.